Annual EBITDA
$1.71 B
-$454.00 M-20.99%
December 31, 2023
Summary
- As of February 12, 2025, VEON annual EBITDA is $1.71 billion, with the most recent change of -$454.00 million (-20.99%) on December 31, 2023.
- During the last 3 years, VEON annual EBITDA has fallen by -$25.00 million (-1.44%).
- VEON annual EBITDA is now -81.66% below its all-time high of $9.32 billion, reached on December 31, 2012.
Performance
VEON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
N/A
September 1, 2024
Summary
- VEON quarterly EBITDA is not available.
Performance
VEON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
N/A
September 1, 2024
Summary
- VEON TTM EBITDA is not available.
Performance
VEON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VEON EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.0% | - | - |
| 3 y3 years | -1.4% | - | - |
| 5 y5 years | -47.6% | - | - |
VEON EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.0% | at low | ||||
| 5 y | 5-year | -55.9% | at low | ||||
| alltime | all time | -81.7% | at low |
VEON EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $439.00 M(-14.3%) | $439.00 M(-14.3%) |
| Dec 2023 | $1.71 B(-21.0%) | - | - |
| Jun 2023 | - | $512.00 M(+13.5%) | $512.00 M(-24.0%) |
| Dec 2022 | $2.16 B(+15.0%) | - | - |
| Jun 2022 | - | $451.00 M(-167.0%) | $674.00 M(-65.0%) |
| Dec 2021 | $1.88 B(+8.5%) | -$673.00 M(-175.1%) | $1.92 B(-24.9%) |
| Sep 2021 | - | $896.00 M(+10.5%) | $2.56 B(+6.6%) |
| Jun 2021 | - | $811.00 M(-8.8%) | $2.40 B(-3.6%) |
| Mar 2021 | - | $889.00 M(-2714.7%) | $2.50 B(-0.8%) |
| Dec 2020 | $1.73 B(-55.2%) | -$34.00 M(-104.6%) | $2.52 B(-19.9%) |
| Sep 2020 | - | $738.00 M(-18.2%) | $3.14 B(-6.9%) |
| Jun 2020 | - | $902.00 M(-0.9%) | $3.37 B(-2.5%) |
| Mar 2020 | - | $910.00 M(+54.0%) | $3.46 B(-10.7%) |
| Dec 2019 | $3.87 B(+18.8%) | $591.00 M(-39.1%) | $3.87 B(-3.8%) |
| Sep 2019 | - | $970.00 M(-2.0%) | $4.03 B(+4.1%) |
| Jun 2019 | - | $990.00 M(-25.2%) | $3.87 B(+4.0%) |
| Mar 2019 | - | $1.32 B(+77.3%) | $3.72 B(+14.2%) |
| Dec 2018 | $3.26 B(-2.9%) | $746.00 M(-8.2%) | $3.26 B(+2.5%) |
| Sep 2018 | - | $813.00 M(-3.4%) | $3.18 B(-7.9%) |
| Jun 2018 | - | $842.00 M(-2.0%) | $3.45 B(+5.4%) |
| Mar 2018 | - | $859.00 M(+29.0%) | $3.28 B(+0.1%) |
| Dec 2017 | $3.36 B(+3.4%) | $666.00 M(-38.7%) | $3.27 B(-2.7%) |
| Sep 2017 | - | $1.09 B(+63.7%) | $3.37 B(+6.1%) |
| Jun 2017 | - | $664.00 M(-22.5%) | $3.17 B(-4.2%) |
| Mar 2017 | - | $857.00 M(+13.2%) | $3.31 B(+2.2%) |
| Dec 2016 | $3.25 B(+41.1%) | $757.00 M(-15.3%) | $3.24 B(+4.6%) |
| Sep 2016 | - | $894.00 M(+11.2%) | $3.10 B(+47.7%) |
| Jun 2016 | - | $804.00 M(+2.2%) | $2.10 B(-10.6%) |
| Mar 2016 | - | $787.00 M(+28.4%) | $2.35 B(+1.9%) |
| Dec 2015 | $2.30 B | $613.00 M(-672.9%) | $2.30 B(+50.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$107.00 M(-110.2%) | $1.53 B(-49.7%) |
| Jun 2015 | - | $1.05 B(+41.4%) | $3.05 B(-26.6%) |
| Mar 2015 | - | $744.00 M(-576.9%) | $4.15 B(-22.2%) |
| Dec 2014 | $4.09 B(+56.1%) | -$156.00 M(-111.1%) | $5.33 B(+461.2%) |
| Sep 2014 | - | $1.41 B(-34.6%) | $950.00 M(-50.5%) |
| Jun 2014 | - | $2.15 B(+11.9%) | $1.92 B(-15.1%) |
| Mar 2014 | - | $1.93 B(-142.4%) | $2.26 B(-13.8%) |
| Dec 2013 | $2.62 B(-71.8%) | -$4.54 B(-290.7%) | $2.62 B(-71.2%) |
| Sep 2013 | - | $2.38 B(-4.7%) | $9.12 B(-1.7%) |
| Jun 2013 | - | $2.50 B(+9.2%) | $9.28 B(+0.0%) |
| Mar 2013 | - | $2.29 B(+16.8%) | $9.27 B(-0.5%) |
| Dec 2012 | $9.32 B(+28.9%) | $1.96 B(-22.9%) | $9.32 B(+6.4%) |
| Sep 2012 | - | $2.54 B(+1.8%) | $8.76 B(+2.7%) |
| Jun 2012 | - | $2.49 B(+7.0%) | $8.52 B(+3.9%) |
| Mar 2012 | - | $2.33 B(+66.9%) | $8.20 B(+13.5%) |
| Dec 2011 | $7.23 B(+44.6%) | $1.40 B(-39.4%) | $7.22 B(+1.0%) |
| Sep 2011 | - | $2.30 B(+6.1%) | $7.15 B(+14.2%) |
| Jun 2011 | - | $2.17 B(+60.0%) | $6.26 B(+19.4%) |
| Mar 2011 | - | $1.36 B(+2.3%) | $5.25 B(+5.0%) |
| Dec 2010 | $5.00 B(+29.9%) | $1.33 B(-6.1%) | $5.00 B(+5.8%) |
| Sep 2010 | - | $1.41 B(+22.5%) | $4.72 B(+5.1%) |
| Jun 2010 | - | $1.15 B(+4.3%) | $4.49 B(-5.9%) |
| Mar 2010 | - | $1.11 B(+5.3%) | $4.77 B(+24.2%) |
| Dec 2009 | $3.85 B(+17.7%) | $1.05 B(-11.2%) | $3.85 B(+37.6%) |
| Sep 2009 | - | $1.18 B(-17.7%) | $2.79 B(+73.3%) |
| Jun 2009 | - | $1.44 B(+711.2%) | $1.61 B(+811.2%) |
| Mar 2009 | - | $176.97 M | $176.97 M |
| Dec 2008 | $3.27 B(-11.8%) | - | - |
| Dec 2007 | $3.71 B(+51.1%) | - | - |
| Dec 2006 | $2.45 B | - | - |
FAQ
- What is VEON annual EBITDA?
- What is the all time high annual EBITDA for VEON?
- What is VEON annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for VEON?
- What is the all time high TTM EBITDA for VEON?
What is VEON annual EBITDA?
The current annual EBITDA of VEON is $1.71 B
What is the all time high annual EBITDA for VEON?
VEON all-time high annual EBITDA is $9.32 B
What is VEON annual EBITDA year-on-year change?
Over the past year, VEON annual EBITDA has changed by -$454.00 M (-20.99%)
What is the all time high quarterly EBITDA for VEON?
VEON all-time high quarterly EBITDA is $2.54 B
What is the all time high TTM EBITDA for VEON?
VEON all-time high TTM EBITDA is $9.32 B